TG
HPTX

TCW Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

TCW Group’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-63,065
Closed -$1.27M – 788
2013
Q4 		$1.27M Sell
63,065
-19,637
-24% -$462K 0.01% 703
2013
Q3 		$2.16M Sell
82,702
-28,612
-26% -$717K 0.01% 649
2013
Q2 		$2.45M Buy
+111,314
New +$2.44M 0.01% 614

Other funds holding HPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HMPV
Highland Management Partners VII Cambridge, Massachusetts $5.57M AUM 94.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCW Group's HPTX Position: Q1 2014 in Review

TCW Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2014, closing a stake of 63,065 shares — an estimated $1.27M sold.

TCW Group first reported a position in HPTX in Q2 2013 and held it in 3 quarters. The position peaked at $2.45M in Q2 2013. 65 funds tracked by Wall St. Rank hold HPTX as of Q1 2014.

  • TCW Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • TCW Group sold 63,065 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2014, an estimated $1.27M.
  • TCW Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • TCW Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.45M in Q2 2013.
  • 65 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2014.

Based on TCW Group's 13F filing for Q1 2014, filed 13 May 2014.